Overview
Neurotrack is a clinical-grade digital health platform that utilizes computer vision and AI to transform standard mobile and desktop cameras into sophisticated eye-tracking diagnostic tools. By analyzing saccadic eye movements and visual recognition memory (VRM), the platform identifies subtle biomarkers of cognitive impairment and Alzheimer's disease years before traditional symptoms manifest. As of 2026, Neurotrack has shifted its market position primarily toward a B2B2C model, integrating directly into health systems and insurance provider workflows (Value-Based Care). The technical architecture is built on top of HIPAA-compliant cloud infrastructure, processing ocular data points in real-time to generate a 'Neurotrack Score' that correlates with established clinical benchmarks like MoCA. The 2026 version features enhanced predictive modeling, utilizing longitudinal data to forecast cognitive decline trajectories with 80%+ accuracy. It bridges the gap between home-based wellness and professional clinical diagnosis, enabling providers to implement early intervention strategies and lifestyle modifications to mitigate dementia risk across large patient populations.